Financials
Value Q2, 25Q3, 25 TTM Selling/general/admin expenses 398.47 M100.37 M — Research & development 279.96 M31.92 M — Operating income 580.67 M6.09 M — Non-Operating Income, Total 4.69 M4.46 M — Interest expense, net of interest capitalized —— — Non-Operating Income, excl. Interest Expenses 4.69 M4.46 M — Unusual income/expense —— — Pretax income 575.98 M1.64 M — Equity in earnings —— — Taxes 300 K200 K — Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations 575.65 M1.84 M — Discontinued operations —— — Net income 575.65 M1.84 M — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 575.65 M1.84 M — Basic earnings per share (Basic EPS) -13.1-0.02 — Diluted earnings per share (Diluted EPS) -13.1-0.02 — Average basic shares outstanding 43.93 M78.86 M — Diluted shares outstanding 43.93 M78.86 M — EBITDA -580.17 M-5.59 M — EBIT -580.67 M-6.09 M — Cost of revenue 41.34 M28.01 M — Other cost of goods sold 00 — Depreciation & amortization (cash flow) 500 K500 K —